Open original FDA record ↗Recall record
- FDA identifier
- Z-2150-2019
- Company in FDA record
- Randox Laboratories, Limited
- FDA record creation date
- Aug 6, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The RX Series control target and range value for ALT (Tris buffer without P5P 37C), Bicarbonate and Gamma-GT has been incorrectly assigned in specific lots of the Human Assayed Multi-Sera Controls.
Source facts
- Action
- On May 25, 2019, the firm notified its customers of the recall via Urgent Medical Device Correction letters. Customers were instructed to do the following: " Review your reagent inventory of these products. Remove all previous versions of the Value Sheets in use and replace with the revised version. " Discuss the contents of this notice with your Medical Director. " Complete and return the response form 12187-QA to t echnical.services@ randox.com within five working days. If you have any questions or concerns, please contact Randox Technical Services.
- Initiated
- 2019-06-11
- Root cause
- Under Investigation by firm
- Terminated
- 2020-05-15
- Distribution
- US Nationwide Distribution - AZ CA CT FL GA IL KY LA MA MD MI MN MO NJ NY OH OK OR PA TX UT VA WA WI WV and PR. Worldwide foreign distribution.
- Recall number
- Z-2150-2019
- Recall status
- Terminated
- CDRH record ID
- 173849
- FDA record created
- 2019-08-06
- Recall event number
- 83155